The electrochemical and chemical oxidation of the defect perovskite SrFeO 2.5 to the cubic perovskite SrFeO 3 at ambient temperature in alkaline electrolyte are shown to be in principle reversible processes with the appearance of intermediate compounds; the oxidation can be described by the formation of line phases SrFeO 2.75 and SrFeO 2.87 and one solid solution range SrFeO 3-x with 0 e x e 0.03. The structure of the brownmillerite type parent phase is characterized by the presence of stacking faults in the octahedral and tetrahedral sequence of layers whose concentration increases significantly upon formation of the intermediate phases. Models based on observed microscopic features are discussed in order to explain the unusual phenomenon of room temperature oxygen transport.
structure structure (solids and liquids) D 2000 47 -011 Room Temperature Electrochemical Redox Reactions of the Defect Perovskite SrFeO 2.5+x . -The electrochemical and chemical oxidation of the defect perovskite SrFeO 2.5 to the cubic perovskite SrFeO 3 at ambient temp. in alkaline electrolyte is shown to be principally reversible. The oxidation occurs via the intermediate phases SrFeO 2.75 , SrFeO 2.87 , and SrFeO 3−δ (0≤δ≤0.003). The structure of the brownmillerite type parent phase is characterized by the presence of stacking faults in the octahedral and tetrahedral sequence of layers whose concentration increases significantly upon formation of the intermediate phases. Tetragonal, cubic, and pseudocubic symmetries can be observed depending on the oxidation rates of the perovskites. -(NEMUDRY, A.; WEISS, M.; GAINUTDINOV, I.; BOLDYREV, V.; SCHOELLHORN, R.; Chem. Mater. 10 (1998) 9, 2403-2411; Inst. Anorg. Anal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.